INTEGRA LIFESCIENCES HOLDINGS CORP (IART) research
INTEGRA LIFESCIENCES HOLDINGS CORP- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $16.02
- As of
INTEGRA LIFESCIENCES HOLDINGS CORP (IART): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-08.
As of . Source: SEC EDGAR filings for IART. Method and limitations.
Share the IART intelligence card
See IART live in the terminal
Track IART's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live IART terminal, freeActive signals for IART
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +131% to IART (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +131% to IART (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +131% to IART (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +131% to IART (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 13.6%, EPS $0.56 vs $0.4931 estimate
FREE, NO ACCOUNT
Every signal on IART, as it fires
You are seeing 5 of 7 signals recorded on IART since 2026-05-26.
The five above landed across 3 days. The other 2 were recorded on 1 other days. 4 of the 7 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in IART (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 457985208 · 2026Q2 | $25.9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 457985208 · 2026Q2 | $9.1M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 457985208 · 2026Q2 | $3.3M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 457985208 · 2026Q2 | $189K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, IART
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
IART against its peers
IART's operating margin of -30.2% ranks in the 36th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | IART | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.6B USD | 218M USD | 88 | 20 |
| Gross margin | n/a | 64.4% | n/a | 19 |
| Operating margin | -30.2% | -16.5% | 36 | 20 |
| Net margin | -31.6% | -13.6% | 31 | 20 |
| Return on equity | -49.5% | -11.8% | 26 | 20 |
Peers (20): AORT, AVNS, BBNX, ENOV, CBLL, INMD, SIBN, QDEL, SSII, ESTA, UFPT, KIDS, DCTH, BFLY, AXGN, SENS, TCMD, NEOG, NPCE, MASS. Left out: LMRI (no annual filing), NHNKF (no annual filing), OSSUY (no annual filing), ALMR (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (IART: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more IART signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to IARTand get the insider, 13F, options, and confluence read in one view.